Abner Herrman & Brock LLC Johnson & Johnson Transaction History

Abner Herrman & Brock LLC

  • $979 Million
  • Q4 2025

A detailed history of Abner Herrman & Brock LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Abner Herrman & Brock LLC holds 3,967 shares of JNJ stock, worth $791,733. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,967
Previous 3,276 21.09%
Holding current value
$791,733
Previous $607,000 35.26%
% of portfolio
0.08%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 06, 2026
BUY
$185.98 - $199.58 $128,512 - $137,909
691 Added 21.09%
3,967 $821,000
Q3 2025

Oct 14, 2025
BUY
$155.17 - $185.42 $508,336 - $607,435
3,276 New
3,276 $607,000
Q2 2024

Jul 18, 2024
SELL
$144.38 - $157.78 $229,275 - $250,554
-1,588 Reduced 41.65%
2,225 $325,000
Q1 2024

Apr 09, 2024
BUY
$155.22 - $162.74 $7,140 - $7,486
46 Added 1.22%
3,813 $603,000
Q4 2023

Jan 09, 2024
BUY
$145.6 - $158.88 $1,164 - $1,271
8 Added 0.21%
3,767 $590,000
Q3 2023

Oct 10, 2023
SELL
$155.75 - $174.48 $2.71 Million - $3.04 Million
-17,401 Reduced 82.24%
3,759 $585,000
Q2 2023

Jul 05, 2023
SELL
$154.35 - $166.11 $7,254 - $7,807
-47 Reduced 0.22%
21,160 $3.5 Million
Q1 2023

Apr 13, 2023
SELL
$151.05 - $180.26 $3.05 Million - $3.64 Million
-20,190 Reduced 48.77%
21,207 $3.29 Million
Q4 2022

Jan 04, 2023
BUY
$160.2 - $179.79 $431,578 - $484,354
2,694 Added 6.96%
41,397 $7.31 Million
Q3 2022

Oct 06, 2022
BUY
$161.33 - $179.52 $3.62 Million - $4.03 Million
22,461 Added 138.29%
38,703 $6.32 Million
Q2 2022

Jul 13, 2022
BUY
$168.19 - $186.01 $232,270 - $256,879
1,381 Added 9.29%
16,242 $2.88 Million
Q1 2022

Apr 07, 2022
SELL
$158.14 - $179.59 $13,283 - $15,085
-84 Reduced 0.56%
14,861 $2.63 Million
Q4 2021

Jan 13, 2022
BUY
$155.93 - $173.01 $27,911 - $30,968
179 Added 1.21%
14,945 $2.56 Million
Q3 2021

Oct 06, 2021
SELL
$161.5 - $179.47 $41,828 - $46,482
-259 Reduced 1.72%
14,766 $2.39 Million
Q2 2021

Jul 09, 2021
SELL
$159.48 - $171.07 $11,163 - $11,974
-70 Reduced 0.46%
15,025 $2.48 Million
Q1 2021

Apr 09, 2021
SELL
$153.07 - $170.48 $62,299 - $69,385
-407 Reduced 2.63%
15,095 $2.48 Million
Q4 2020

Jan 12, 2021
SELL
$137.11 - $157.38 $1.31 Million - $1.5 Million
-9,531 Reduced 38.07%
15,502 $2.44 Million
Q3 2020

Oct 08, 2020
SELL
$140.38 - $153.83 $166,209 - $182,134
-1,184 Reduced 4.52%
25,033 $3.73 Million
Q2 2020

Jul 10, 2020
BUY
$128.81 - $155.51 $79,991 - $96,571
621 Added 2.43%
26,217 $3.69 Million
Q1 2020

Apr 09, 2020
BUY
$111.14 - $153.99 $113,918 - $157,839
1,025 Added 4.17%
25,596 $3.36 Million
Q4 2019

Jan 10, 2020
SELL
$127.5 - $146.44 $8.47 Million - $9.73 Million
-66,464 Reduced 73.01%
24,571 $3.58 Million
Q3 2019

Oct 11, 2019
SELL
$126.95 - $142.14 $3.39 Million - $3.79 Million
-26,682 Reduced 22.67%
91,035 $11.8 Million
Q2 2019

Jul 19, 2019
SELL
$131.15 - $144.24 $256,529 - $282,133
-1,956 Reduced 1.63%
117,717 $16.4 Million
Q1 2019

Apr 08, 2019
BUY
$125.72 - $139.79 $5.1 Million - $5.67 Million
40,530 Added 51.21%
119,673 $16.7 Million
Q4 2018

Jan 11, 2019
BUY
$122.84 - $147.84 $3.7 Million - $4.46 Million
30,157 Added 61.56%
79,143 $10.2 Million
Q3 2018

Oct 19, 2018
BUY
$121.58 - $142.88 $1.55 Million - $1.83 Million
12,784 Added 35.31%
48,986 $6.77 Million
Q2 2018

Jul 06, 2018
SELL
$119.4 - $131.76 $132,653 - $146,385
-1,111 Reduced 2.98%
36,202 $4.39 Million
Q1 2018

Apr 06, 2018
BUY
$125.1 - $148.14 $804,518 - $952,688
6,431 Added 20.82%
37,313 $4.78 Million
Q4 2017

Jan 05, 2018
BUY
$131.22 - $143.62 $320,832 - $351,150
2,445 Added 8.6%
30,882 $4.32 Million
Q3 2017

Oct 06, 2017
BUY
$129.47 - $135.38 $3.68 Million - $3.85 Million
28,437
28,437 $3.7 Million

Others Institutions Holding JNJ

# of Institutions
4,831
Shares Held
1.74B
Call Options Held
19.8M
Put Options Held
16.8M
View Full List

About JOHNSON & JOHNSON

JNJ Quotes by TradingView
  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $522B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Abner Herrman & Brock LLC Portfolio

Follow Abner Herrman & Brock LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abner Herrman & Brock LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abner Herrman & Brock LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email